1907
永豐餘
-0.15 (-0.52%)28.85556成交張數16.97本益比0.53股價淨值比3.47%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入202573,643年增 -6.1%
毛利率202513.0%最新一期
營業利益率2025-1.1%最新一期
每股盈餘20251.19年增 +21.4%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | +5.4% | +14.5% | -2.2% | -2.0% | +16.5% | -6.6% | -7.2% | +6.2% | -6.1% | |
| 營業成本合計 | – | +3.7% | +18.2% | -3.9% | -6.3% | +15.3% | +2.0% | -6.9% | +6.6% | -5.7% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | – | – | – | +919.5% | -170.8% | – | – | -398.9% | |
| 營業毛利（毛損） | – | +14.0% | -2.7% | +7.5% | +19.3% | +21.2% | -38.8% | -9.3% | +3.4% | -8.5% | |
| 營業毛利（毛損）淨額 | – | +14.0% | -2.7% | +7.5% | +19.3% | +21.2% | -38.8% | -9.3% | +3.4% | -8.5% | |
| 營業費用合計 | – | -3.8% | +3.1% | +2.6% | -2.0% | +8.1% | -1.7% | -0.2% | +6.4% | -2.0% | |
| 營業利益（損失） | – | +165.6% | -20.3% | +26.7% | +87.3% | +43.0% | -85.7% | -88.0% | -212.0% | – | |
| 稅前淨利（淨損） | – | +194.6% | +3.1% | +21.5% | +135.5% | +16.6% | -63.3% | -28.6% | +6.8% | -1.8% | |
| 所得稅費用（利益）合計 | – | +73.0% | +36.7% | -7.2% | +97.7% | +13.3% | -63.2% | -37.6% | +3.4% | +9.0% | |
| 繼續營業單位本期淨利（淨損） | – | +284.1% | -8.1% | +35.7% | +148.3% | +17.5% | -63.3% | -26.2% | +7.5% | -4.1% | |
| 本期淨利（淨損） | – | +284.1% | -8.1% | +35.7% | +148.3% | +17.5% | -63.3% | -26.2% | +7.5% | -4.1% | |
| 本期綜合損益總額 | – | – | +55.4% | +146.1% | +26.6% | +71.6% | -41.3% | -17.8% | +87.4% | +6.6% | |
| 母公司業主（淨利∕損） | – | – | -10.4% | +58.7% | +127.9% | -0.1% | -58.3% | -15.8% | -10.7% | +21.0% | |
| 基本每股盈餘 | – | – | -10.3% | +58.6% | +127.5% | -0.3% | -58.1% | -16.0% | -10.9% | +21.4% |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。